| 武汉天德生物病理生物芯片系列-LUC1505 | ||||||||
| 芯片编号 | LUC1505 | |||||||
| 芯片名称 | 肺腺癌,75例,150芯(1.5mm),系列5 | |||||||
| 芯片说明 | 肺腺癌组织芯片,系列5,75例,150芯,包括癌和自体癌旁组织,提供病理分级和TNM分期数据,临床资料及生存期。 | |||||||
| 点数: | 150 | |||||||
| 例数: | 75 | |||||||
| 组织固定方式: | 福尔马林固定24h | |||||||
| QA/QC: | HE染色和IHC染色 | |||||||
| 应用: | 常规组织学操作包括免疫组织化学(IHC)和原位杂交(ISH),可以在我们的技术支持页面找到操作流程。 | |||||||
| 注意事项: | 1.收到产品后请常温保存,并在24个月内使用,2.请在实验前60°烤片30分钟,3.请选择温和的修复方式,以免造成组织脱落。 | |||||||
| 位置 | 年龄 | 性别 | 标本部位 | 病理分类 | 肿瘤新分类 | TNM_T | TNM_N | TNM_M |
| A1,B1 | 59 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T2 | N0 | M0 |
| A2,B2 | 61 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T2 | N0 | M0 |
| A3,B3 | 49 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,实性为主型 | T2 | N0 | M0 |
| A4,B4 | 58 | F | 肺,Lung | 细支气管肺泡癌;Bronchioloalveolar carcinoma | 浸润性腺癌,腺泡为主型 | T2 | N0 | M0 |
| A5,B5 | 44 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T2 | N0 | M0 |
| A6,B6 | 58 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T3 | N1 | M0 |
| A7,B7 | 57 | M | 肺,Lung | 细支气管肺泡癌;Bronchioloalveolar carcinoma | 浸润性腺癌,乳头为主型 | T2 | N0 | M0 |
| A8,B8 | 42 | M | 肺,Lung | 细支气管肺泡癌;Bronchioloalveolar carcinoma | 浸润性腺癌,乳头为主型 | T2 | N1 | M0 |
| A9,B9 | 60 | M | 肺,Lung | 细支气管肺泡癌;Bronchioloalveolar carcinoma | 浸润性腺癌,乳头为主型 | T2 | N1 | M0 |
| A10,B10 | 65 | F | 肺,Lung | 乳头状腺癌;Papillary carcinoma | 浸润性腺癌,(粘液腺癌) | T4 | N0 | M0 |
| A11,B11 | 47 | M | 肺,Lung | 细支气管肺泡癌;Bronchioloalveolar carcinoma | 浸润性腺癌,乳头为主型 | T2 | N0 | M0 |
| A12,B12 | 74 | M | 肺,Lung | 细支气管肺泡癌;Bronchioloalveolar carcinoma | 浸润性腺癌,腺泡为主型 | T3 | N0 | M0 |
| A13,B13 | 55 | F | 肺,Lung | 细支气管肺泡癌;Bronchioloalveolar carcinoma | 浸润性腺癌,粘液型 | T2 | N0 | M0 |
| A14,B14 | 44 | F | 肺,Lung | 细支气管肺泡癌;Bronchioloalveolar carcinoma | 浸润性腺癌,腺泡为主型 | T2 | N0 | M0 |
| A15,B15 | 55 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T3 | N1 | M0 |
| C1,D1 | 70 | M | 肺,Lung | 细支气管肺泡癌;Bronchioloalveolar carcinoma | 浸润性腺癌,腺泡为主型 | T3 | N1 | M0 |
| C2,D2 | 63 | M | 肺,Lung | 细支气管肺泡癌;Bronchioloalveolar carcinoma | 浸润性腺癌,腺泡为主型 | T2 | N1 | M0 |
| C3,D3 | 60 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T2 | N1 | M0 |
| C4,D4 | 65 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,乳头为主型 | T2 | N1 | M0 |
| C5,D5 | 60 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T2 | N0 | M0 |
| C6,D6 | 80 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T3 | N0 | M0 |
| C7,D7 | 66 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,乳头为主型 | T2 | N0 | M0 |
| C8,D8 | 45 | M | 肺,Lung | 细支气管肺泡癌;Bronchioloalveolar carcinoma | 浸润性粘液腺癌 | T2 | N1 | M0 |
| C9,D9 | 52 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,乳头为主型 | T2 | N1 | M0 |
| C10,D10 | 58 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T2 | N1 | M0 |
| C11,D11 | 64 | F | 肺,Lung | 细支气管肺泡癌;Bronchioloalveolar carcinoma | 浸润性腺癌,乳头为主型 | T3 | N1 | M0 |
| C12,D12 | 70 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T3 | N1 | M0 |
| C13,D13 | 39 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,乳头为主型 | T2 | N1 | M0 |
| C14,D14 | 59 | F | 肺,Lung | 乳头状腺癌;Papillary carcinoma | 浸润性腺癌,乳头为主型 | T2 | N1 | M0 |
| C15,D15 | 37 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T2 | N0 | M0 |
| E1,F1 | 69 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,乳头为主型 | T2 | N1 | M0 |
| E2,F2 | 55 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T2 | N0 | M0 |
| E3,F3 | 72 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,乳头为主型 | T2 | N0 | M0 |
| E4,F4 | 75 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,实性为主型 | T2 | N0 | M0 |
| E5,F5 | 70 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,乳头为主型 | T1 | N0 | M0 |
| E6,F6 | 51 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,微乳头为主型 | T2 | N1 | M0 |
| E7,F7 | 60 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T2 | N1 | M0 |
| E8,F8 | 62 | M | 肺,Lung | 细支气管肺泡癌;Bronchioloalveolar carcinoma | 浸润性腺癌,腺泡为主型 | T1 | N0 | M0 |
| E9,F9 | 57 | F | 肺,Lung | 细支气管肺泡癌;Bronchioloalveolar carcinoma | 浸润性腺癌,乳头为主型 | T2 | N1 | M0 |
| E10,F10 | 60 | F | 肺,Lung | 细支气管肺泡癌;Bronchioloalveolar carcinoma | 浸润性腺癌,乳头为主型 | T2 | N0 | M0 |
| E11,F11 | 53 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,乳头为主型 | T2 | N1 | M0 |
| E12,F12 | 32 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T1 | N0 | M0 |
| E13,F13 | 69 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,实性为主型 | T2 | N1 | M0 |
| E14,F14 | 57 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T1 | N1 | M0 |
| E15,F15 | 61 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,实性为主型 | T2 | N1 | M0 |
| G1,H1 | 64 | F | 肺,Lung | 腺癌;Adenocarcinoma | 胎儿型腺癌 | T2 | N0 | M0 |
| G2,H2 | 55 | M | 肺,Lung | 细支气管肺泡癌;Bronchioloalveolar carcinoma | 浸润性腺癌,乳头为主型 | T2 | N1 | M0 |
| G3,H3 | 51 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,乳头为主型 | T2 | N1 | M0 |
| G4,H4 | 40 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T2 | N1 | M0 |
| G5,H5 | 61 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,实性为主型伴粘液产生 | T2 | N0 | M0 |
| G6,H6 | 55 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T2 | N1 | M0 |
| G7,H7 | 73 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,实性为主型 | T2 | N1 | M0 |
| G8,H8 | 67 | M | 肺,Lung | 乳头状腺癌;Papillary carcinoma | 浸润性腺癌,微乳头型 | T2 | N0 | M0 |
| G9,H9 | 58 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,实性为主型伴粘液产生 | T2 | N1 | M0 |
| G10,H10 | 61 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T1 | N0 | M0 |
| G11,H11 | 57 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,实性为主型伴粘液产生 | T2 | N1 | M0 |
| G12,H12 | 67 | M | 肺,Lung | 粘液腺癌;Mucinous adenocarcinoma | 粘液腺癌 | T1 | N1 | M0 |
| G13,H13 | 59 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,实性为主型 | T2 | N1 | M0 |
| G14,H14 | 60 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T3 | N0 | M0 |
| G15,H15 | 53 | M | 肺,Lung | 鳞癌;Squamous cell carcinoma | 浸润性腺癌,实性为主型伴粘液产生 | T2 | N1 | M0 |
| I1,J1 | 54 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T3 | N0 | M0 |
| I2,J2 | 57 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,实性为主型 | T2 | N1 | M0 |
| I3,J3 | 61 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,乳头为主型 | T2 | N0 | M0 |
| I4,J4 | 48 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,实性为主型 | T1 | N1 | M0 |
| I5,J5 | 60 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T2 | N0 | M0 |
| I6,J6 | 58 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,肠型 | T1 | N1 | M0 |
| I7,J7 | 47 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,附壁为主型 | T2 | N0 | M0 |
| I8,J8 | 56 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌(粘液腺癌) | T2 | N1 | M0 |
| I9,J9 | 60 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T2 | N1 | M0 |
| I10,J10 | 73 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,乳头为主型 | T1 | N0 | M0 |
| I11,J11 | 70 | F | 肺,Lung | 细支气管肺泡癌;Bronchioloalveolar carcinoma | 浸润性腺癌,腺泡为主型 | T2 | N0 | M0 |
| I12,J12 | 62 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T1 | N1 | M0 |
| I13,J13 | 60 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,肠型 | T1 | N0 | M0 |
| I14,J14 | 53 | F | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,腺泡为主型 | T1 | N1 | M0 |
| I15,J15 | 59 | M | 肺,Lung | 腺癌;Adenocarcinoma | 浸润性腺癌,实性为主型 | T2 | N0 | M0 |